FDA inspection
Merck Sharp & Dohme LLC: FDA inspection ending Feb 13, 2026
FDA inspection 1307924 · Voluntary Action Indicated (VAI) · Wilson, NC
Key facts
| Inspection ID | 1307924 |
|---|---|
| Firm | Merck Sharp & Dohme LLC |
| FEI number | 1036761 |
| Address | 4633 Merck Rd W |
| City | Wilson |
| State | NC |
| ZIP | 27893-9613 |
| Fiscal year | 2026 |
| Inspection end date | Feb 13, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Vaccine, Allergenic, and Live Biotherapeutic Products |
| Product type | Biologics, Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data